Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

Supreme Court Denies Cert Petition in Lovenox Case

By Aaron Barkoff

Aventis Pharma v. Amphastar and Teva, S. Ct. Appeal No. 08-937 (2009)The Supreme Court on Monday denied Aventis Pharma's cert petition in a long-running dispute with generic biopharmaceutical manufacturer Amphastar.  In its petition, Aventis had asked the Court to review a Federal Circuit decision affirming the unenforceability of its patent on Lovenox.  In particular, Aventis asked the Court to overturn the Federal Circuit's "sliding scale" doctrine-?the doctrine t read more

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on April 29, 2009 (boomark / email).